FORM 4

 o Check this box if no longer subject to Section 16.  Form 4 or Form 5 obligations may continue.
See Instruction 1(b).

(Print or Type Responses)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the
Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . 0.5

 

 1. Name and Address of Reporting Person *



Clemens IV,            Peter             J.

(Last)            (First)              (Middle)


3000 Galleria Tower, Suite 1000

(Street)


Birmingham,            AL            35244

(City)       (State)          (Zip)

 

 2. Issuer Name and Ticker
    or Trading Symbol

Caremark Rx, Inc.   CMX



 3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

 

 

 4. Statement for
    Month/Day/Year

April 2, 2003





 5. If Amendment, Date of
    Original (Month/Day/Year)

 

 


 6. Relationship of Reporting Person(s) to Issuer

     (Check all applicable)

      Director

 

   X   Officer (give title below)

 

      10% Owner

 

      Other (specify below)

  


 7. Individual or Joint/Group
     Filing (Check Applicable Line)

   X   Form filed by One Reporting Person

      Form filed by More than One Reporting Person

 

Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

 

1. Title of Security
(Instr. 3)

2. Transaction Date (Month/Day/
Year)

2A. Deemed Execution Date, if any (Month/Day/
Year)

3. Transaction Code
(Instr. 8)

4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)

5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)

6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)

7. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

V

Amount

(A) or (D)

Price

Common Stock, par value $.001

 

 

 

 

 

 

 

4,626.39(1)

D

Carestock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

Table II — Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

 

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date
(Month/Day/
Year)

3A. Deemed Execution Date, if any (Month/Day/
Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Securities: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

V

(A)

(D)

Date
Exercisable

Expiration
Date

Title

Amount or Number of Shares

Stock Option

$12.00

2/6/95

 

(A)

 

(1)

 

2/6/95(2)

2/6/05

Common Stock, $.001 par value

10,000

 

10,000

D

 

Stock Option

$16.625

7/24/96

 

(A)

 

(1)

 

7/24/96(2)

7/24/06

Common Stock, $.001 par value

4,750

 

4,750

D

 

Stock Option

$3.00

9/21/98

 

(A)

 

(1)

 

9/21/98(3)

9/21/08

Common Stock, $.001 par value

16,000

 

16,000

D

 

Stock Option

$3.00

9/21/98

 

(A)

 

(1)

 

9/21/98(3)

9/21/08

Common Stock, $.001 par value

19,250

 

19,250

D

 

Stock Option

$3.00

9/21/98

 

(A)

 

(1)

 

9/21/98(3)

9/21/08

Common Stock, $.001 par value

1,000

 

1,000

D

 

Stock Option

$4.1875

4/8/99

 

(A)

 

(1)

 

4/8/99(3)

4/8/09

Common Stock, $.001 par value

25,000

 

25,000

D

 

Stock Option

$5.0625

10/13/99

 

(A)

 

(1)

 

10/13/99 (3)

10/13/09

Common Stock, $.001 par value

50,000

 

50,000

D

 

Stock Option

$12.25

1/12/01

 

(A)

 

(1)

 

1/12/01(3)

1/12/11

Common Stock, $.001 par value

50,000

 

50,000

D

 

Stock Option

$13.21

11/7/01

 

(A)

 

(1)

 

11/7/01(3)

11/7/11

Common Stock, $.001 par value

50,000

 

50,000

D

 

Stock Option

$18.35

4/2/03

 

(A)

 

20,000

 

4/2/03(3)

4/2/03

Common Stock, $.001 par value

20,000

 

20,000

D

 

 

 

 Explanation of Responses:

(1)  Previously reported, for information purposes only.  (2) 20% of these options are exercisable on the grant date, and 20% on each anniversary of the grant date.  (3)  34% of these options are exercisable on  grant date, and 33% on each of the 1st and 2nd anniversaries of  grant date.

 

 

/s/ Peter J. Clemens

** Signature of Reporting Person

4/3/03

Date

 

 

 

 

 

 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

 

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
      See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

 

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

 

 

http://www.sec.gov/divisions/corpfin/forms/form4.htm

Last update: 09/05/2002